These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6959449)

  • 1. Cytologic monitoring of women using copper-containing intrauterine devices: five-year follow-up study.
    Luthra UK; Mitra AB; Prabhakar AK; Agarwal SS; Bhatnagar P
    Acta Cytol; 1982; 26(5):619-22. PubMed ID: 6959449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term cytologic studies of copper-IUD users.
    Engineer AD; Misra JS; Tandon P
    Acta Cytol; 1981; 25(5):550-6. PubMed ID: 6945020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cytology associated with levonorgestrel contraception.
    Misra JS; Engineer AD; Tandon P
    Acta Cytol; 1995; 39(1):45-9. PubMed ID: 7847008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper containing intrauterine devices and cervical carcinogenesis--48 months follow up.
    Luthra UK; Mitra AB; Prabhakar AK; Bhatnagar P; Agarwal SS
    Indian J Med Res; 1980 Nov; 72():659-64. PubMed ID: 7203566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytologic studies after insertion of intrauterine contraceptive devices (IUD) (author's transl)].
    Prinz W; Noack J; Kraus H; Schuhmann RA
    Geburtshilfe Frauenheilkd; 1981 Mar; 41(3):194-8. PubMed ID: 7215760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term clinical observation on VCu200 intrauterine devices].
    Wu XZ; Lu J; Li HQ
    Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):545-7, 544-5. PubMed ID: 7835133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytological monitoring of femal genital tract in women using Cu-IUD.
    Luthra UK; Mitra AB; Prabhakar AK; Bhatnagar P
    Indian J Med Res; 1977 Aug; 66(2):216-22. PubMed ID: 924593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytopathological changes in human cervix and endometrium following prolonged retention of copper-bearing intrauterine contraceptive devices.
    Misra JS; Engineer AD; Tandon P
    Diagn Cytopathol; 1989; 5(3):237-42. PubMed ID: 2791830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytological complications of IUDs (author's transl)].
    Saurel J; Marc J; Audebert A; Malgouyat R; Morard JL
    Arch Anat Cytol Pathol; 1982; 30(1):20-4. PubMed ID: 7082054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of cervical neoplasia and infection in women using intrauterine contraceptive devices.
    Blenkinsopp WK; Chapman P
    J Reprod Med; 1982 Nov; 27(11):709-13. PubMed ID: 7153984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of actinomycosis associated with intrauterine devices.
    Chatwani A; Amin-Hanjani S
    J Reprod Med; 1994 Aug; 39(8):585-7. PubMed ID: 7996521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative cervical cytology in women using different types of copper IUDs.
    Engineer AD; Misra JS; Tandon P
    Indian J Med Res; 1981 Jul; 74():23-30. PubMed ID: 7309184
    [No Abstract]   [Full Text] [Related]  

  • 16. The copper-7 intrauterine contraceptive device: 5-year evaluation.
    Sellors JW
    Can Med Assoc J; 1981 Oct; 125(7):717-20. PubMed ID: 7326653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytological complications of IUDs ].
    Saurel J; Marc J; Audebert A; Malgouyat R; Morard JL
    Sem Hop; 1982 Jul; 58(28-29):1703-7. PubMed ID: 6289452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A reanalysis of the Cu-7 intrauterine contraceptive device clinical trial and the incidence of pelvic inflammatory disease: a paradigm for assessing intrauterine contraceptive device safety.
    Roy S; Azen C
    Am J Obstet Gynecol; 1994 Jun; 170(6):1606-13; discussion 1613-6. PubMed ID: 8203417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of intrauterine contraceptive device (copper T 200 B) in women with cardiac disease.
    Suri V; Aggarwal N; Kaur R; Chaudhary N; Ray P; Grover A
    Contraception; 2008 Oct; 78(4):315-8. PubMed ID: 18847580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.